AAM REPORT

A Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain

A closely connected, diverse and resilient pharmaceutical supply chain based in the United States and in U.S. allied countries (for example, Canada, Europe, India, Israel and Jordan) is the best means to ensure that U.S. patients and the U.S. health care system have access to a secure and consistent supply of critical pharmaceuticals. The United States already plays an important role in this supply chain, with generic companies providing for more than 52,000 jobs at nearly 150 facilities, and manufacturing more than 60 billion doses of prescription medicines annually.1

1. AAM Member Survey and other sources.